Jean represents numerous national and international clients, including several Fortune 500 pharmaceutical corporations, start-up biotechnology and pharmaceutical companies and major U.S. universities. Jean regularly counsels these clients in all aspects of intellectual property, with an emphasis on strategic patent portfolio development and procurement, patent infringement and validity analysis, due diligence analysis of intellectual patent portfolios as a part of mergers and acquisitions, and intellectual property licensing in a variety of technologies, including:

  • pharmaceuticals;
  • chemicals;
  • biotechnology;
  • medical devices;
  • diagnostics;
  • cosmetics;
  • food sciences;
  • animal health products;
  • personal care products;
  • consumer products;
  • bioinformatics;
  • computer and software arts; and
  • mechanical arts.